HTA at IQVIA

Seoul, South Korea, South Korea

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, PharmaceuticalsIndustries

Requirements

Master or PhD level in Health Policy, Pharmaco-economics, Public Health, Epidemiology, Pharmacy administration, data science or related fields
7+ years of experience in the HEOR/RWE area in consulting/pharma/academia
Strong analytical skills, proficiency in statistical software such as R and SAS
Track record of publications in English peer-reviewed journals
Excellent English writing abilities

Responsibilities

Develop and implement research related to the Health Economics, Outcomes Research & Real-World Evidence business areas (economic modelling, observational studies, systematic reviews & meta-analysis, value communication, pricing & market access strategy)
Develop value-evidence strategies, product value dossiers and value communications for clients
Design and conduct observational studies: protocol development, methodology/statistical analysis plan, study reports, manuscript writing, etc
Project management / client liaison including client management tasks, attend client and other external meetings and presentations of own research / analysis
Carry out research and draft dossier / reports for projects delivering strategic advice to clients on pricing, reimbursement and market access

Skills

Health Economics

Outcomes Research

Real-World Evidence

Economic Modelling

Observational Studies

Systematic Reviews

Meta-Analysis

Value Dossiers

Network Meta-Analysis

Pricing Strategy

Market Access

Pharmaco-economics

Epidemiology

Statistical Analysis

Protocol Development

IQVIA

Advanced analytics and clinical research services

About IQVIA

IQVIA provides advanced analytics, technology solutions, and clinical research services specifically for the life sciences industry. Their services utilize extensive data resources and technology to create connections within healthcare, allowing clients to gain insights that help speed up the development and marketing of new medical treatments. This process is facilitated by their IQVIA Connected Intelligence™ system, which offers quick and flexible insights. IQVIA stands out from competitors by focusing on patient privacy, employing various technologies to protect individual data. The company's goal is to enhance healthcare outcomes by supporting biotech, pharmaceutical, and medical device companies, as well as researchers and government agencies, in understanding diseases and advancing medical science.

Durham, North CarolinaHeadquarters

1998Year Founded

$3,526MTotal Funding

POST_IPO_EQUITYCompany Stage

Cybersecurity, Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Rapid advancement of cancer vaccines may disrupt traditional clinical research models.

Proliferation of disparate technological solutions causes technology overload in clinical trials.

Generative AI technologies face challenges in adoption due to data privacy concerns.

Differentiation

IQVIA leverages advanced analytics and big data for life sciences solutions.

The company offers privacy-enhancing technologies to protect individual patient data.

IQVIA's AI Assistant provides rapid, actionable insights for healthcare and life sciences.

Upsides

Increased adoption of decentralized clinical trials enhances patient-centric study designs.

AI-driven drug discovery accelerates identification of potential drug candidates.

Expansion of telemedicine facilitates remote patient monitoring and data collection.

Land your dream remote job 3x faster with AI

Try Jobo Free